Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) Equity Average (2017 - 2025)

Selectis Health's Equity Average history spans 13 years, with the latest figure at -$6.0 million for Q3 2025.

  • For Q3 2025, Equity Average fell 49.62% year-over-year to -$6.0 million; the TTM value through Sep 2025 reached -$6.0 million, down 49.62%, while the annual FY2024 figure was -$4.2 million, 316.42% down from the prior year.
  • Equity Average for Q3 2025 was -$6.0 million at Selectis Health, up from -$6.2 million in the prior quarter.
  • Across five years, Equity Average topped out at $3.9 million in Q2 2023 and bottomed at -$6.2 million in Q2 2025.
  • The 5-year median for Equity Average is $2.1 million (2022), against an average of -$61996.1.
  • The largest annual shift saw Equity Average skyrocketed 726.74% in 2021 before it tumbled 347.92% in 2024.
  • A 5-year view of Equity Average shows it stood at $3.2 million in 2021, then tumbled by 36.41% to $2.1 million in 2022, then tumbled by 155.37% to -$1.1 million in 2023, then crashed by 347.92% to -$5.1 million in 2024, then dropped by 17.62% to -$6.0 million in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Equity Average are -$6.0 million (Q3 2025), -$6.2 million (Q2 2025), and -$5.7 million (Q1 2025).